High-throughput compound screening identifies navitoclax combined with irradiation as a candidate therapy for HPV-negative head and neck squamous cell carcinoma

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number14755
JournalScientific Reports
Volume11
Number of pages10
ISSN2045-2322
DOIs
Publication statusPublished - 20 Jul 2021
MoE publication typeA1 Journal article-refereed

Fields of Science

  • CANCER
  • COMBINATION
  • 3122 Cancers

Cite this